Simulating sleep apnea by exposure to intermittent hypoxia induces inflammation in the lung and liver

Mediators of Inflammation

Volumn 2012, Issue , 2012, Pages

  Da Rosa, Darlan Pase ^a,b,c   Forgiarini, Luiz Felipe ^a,b   Baronio, Diego ^a,b   Feijó, Cristiano Andrade ^a,b   Martinez, Dênis ^a,b   Marroni, Norma Possa ^a,b,d  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^c Faculdade Cenecista de Bento Gonçalves   (Brazil)

^d UNIVERSIDADE LUTERANA DO BRASIL   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; HYPOXIA INDUCIBLE FACTOR 1ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; HIF1A PROTEIN, MOUSE; NITRIC OXIDE; VASCULOTROPIN A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HEPATITIS; INTERMITTENT HYPOXIA; LIPID PEROXIDATION; MOUSE; NONHUMAN; OXIDATIVE STRESS; PNEUMONIA; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN INDUCTION; SLEEP DISORDERED BREATHING; ANIMAL; ANOXIA; BIOSYNTHESIS; C57BL MOUSE; METABOLISM;

ANIMALIA; MUS;

ANIMALS; ANOXIA; HEPATITIS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MICE; MICE, INBRED C57BL; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; OXIDATIVE STRESS; PNEUMONIA; SLEEP APNEA, OBSTRUCTIVE; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84871667781     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2012/879419     Document Type: Article

References (61)

1. Dempsey J. A., Veasey S. C., Morgan B. J., O'Donnell C. P., Pathophysiology of sleep apnea. Physiological Reviews 2010 90 1 47 112 2-s2.0-74949136860 10.1152/physrev.00043.2008
2. Lavie L., Obstructive sleep apnoea syndrome-an oxidative stress disorder. Sleep Medicine Reviews 2003 7 1 35 51 2-s2.0-0037316130 10.1053/smrv.2002.0261
3. Lavie L., Sleep-disordered breathing and cerebrovascular disease: a mechanistic approach. Neurologic Clinics 2005 23 4 1059 1075 2-s2.0-27144536591 10.1016/j.ncl.2005.05.005
4. Suzuki Y. J., Jain V., Park A. M., Day R. M., Oxidative stress and oxidant signaling in obstructive sleep apnea and associated cardiovascular diseases. Free Radical Biology and Medicine 2006 40 10 1683 1692 2-s2.0-33746701376 10.1016/j.freeradbiomed.2006.01.008
5. Lavie L., Oxidative stress-A unifying paradigm in obstructive sleep apnea and comorbidities. Progress in Cardiovascular Diseases 2009 51 4 303 312 2-s2.0-57749100366 10.1016/j.pcad.2008.08.003
6. Aalto T. K., Raivio K. O., Nucleotide depletion due to reactive oxygen metabolites in endothelial cells: effects of antioxidants and 3-aminobenzamide. Pediatric Research 1993 34 5 572 576 2-s2.0-0027458059
7. Szabó C., Zingarelli B., Salzman A. L., Role of poly-ADP ribosyltransferase activation in the vascular contractile and energetic failure elicited by exogenous and endogenous nitric oxide and peroxynitrite. Circulation Research 1996 78 6 1051 1063 2-s2.0-0029934194
8. Zhang J., Dawson V. L., Dawson T. M., Snyder S. H., Nitric oxide activation of poly(ADP-ribose) synthetase in neurotoxicity. Science 1994 263 5147 687 689 2-s2.0-0028294246
9. Singh H., Pollock R., Uhanova J., Kryger M., Hawkins K., Minuk G. Y., Symptoms of obstructive sleep apnea in patients with nonalcoholic fatty liver disease. Digestive Diseases and Sciences 2005 50 12 2338 2343 2-s2.0-30844460632 10.1007/s10620-005-3058-y
10. Tanné F., Gagnadoux F., Chazouillères O., Fleury B., Wendum D., Lasnier E., Lebeau B., Poupon R., Serfaty L., Chronic liver injury during obstructive sleep apnea. Hepatology 2005 41 6 1290 1296 2-s2.0-20044378321 10.1002/hep.20725
11. Tatsumi K., Saibara T., Effects of obstructive sleep apnea syndrome on hepatic steatosis and nonalcoholic steatohepatitis. Hepatology Research 2005 33 2 100 104 2-s2.0-29144450654 10.1016/j.hepres.2005.09.014
12. Jouët P., Sabaté J. M., Maillard D., Msika S., Mechler C., Ledoux S., Harnois F., Coffin B., Relationship between obstructive sleep apnea and liver abnormalities in morbidly obese patients: a prospective study. Obesity Surgery 2007 17 4 478 485 2-s2.0-34249800116 10.1007/s11695-007-9085-3
13. Kallwitz E. R., Herdegen J., Madura J., Jakate S., Cotler S. J., Liver enzymes and histology in obese patients with obstructive sleep apnea. Journal of Clinical Gastroenterology 2007 41 10 918 921 2-s2.0-37349033894 10.1097/01.mcg.0000225692.62121.55
14. Zamora-Valdés D., Méndez-Sánchez N., Experimental evidence of obstructive sleep apnea syndrome as a second hit accomplice in nonalcoholic steatohepatitis pathogenesis. Annals of Hepatology 2007 6 4 281 283 2-s2.0-37549050510
15. Kheirandish-Gozal L., Sans Capdevila O., Kheirandish E., Gozal D., Elevated serum aminotransferase levels in children at risk for obstructive sleep apnea. Chest 2008 133 1 92 99 2-s2.0-38349073396 10.1378/chest.07-0773
16. Norman D., Bardwell W. A., Arosemena F., Nelesen R., Mills P. J., Loredo J. S., Lavine J. E., Dimsdale J. E., Serum aminotransferase levels are associated with markers of hypoxia in patients with obstructive sleep apnea. Sleep 2008 31 1 121 126 2-s2.0-37549010264
17. Savransky V., Nanayakkara A., Vivero A., Li J., Bevans S., Smith P. L., Torbenson M. S., Polotsky V. Y., Chronic intermittent hypoxia predisposes to liver injury. Hepatology 2007 45 4 1007 1013 2-s2.0-34247359442 10.1002/hep.21593
18. Savransky V., Reinke C., Jun J., Bevans-Fonti S., Nanayakkara A., Li J., Myers A. C., Torbenson M. S., Polotsky V. Y., Chronic intermittent hypoxia and acetaminophen induce synergistic liver injury in mice: experimental physiology-research paper. Experimental Physiology 2009 94 2 228 239 2-s2.0-58449102202 10.1113/expphysiol.2008.044883
19. Ryan S., Taylor C. T., McNicholas W. T., Systemic inflammation: a key factor in the pathogenesis of cardiovascular complications in obstructive sleep apnoea syndrome? Thorax 2009 64 7 631 636 2-s2.0-67650266752 10.1136/thx.2008.105577
20. Htoo A. K., Greenberg H., Tongia S., Chen G., Henderson T., Wilson D., Liu S. F., Activation of nuclear factor B in obstructive sleep apnea: a pathway leading to systemic inflammation. Sleep and Breathing 2006 10 1 43 50 2-s2.0-33645114153 10.1007/s11325-005-0046-6
21. Greenberg H., Ye X., Wilson D., Htoo A. K., Hendersen T., Liu S. F., Chronic intermittent hypoxia activates nuclear factor- B in cardiovascular tissues in vivo. Biochemical and Biophysical Research Communications 2006 343 2 591 596 2-s2.0-33645122617 10.1016/j.bbrc.2006.03.015
22. Selmi C., Montano N., Furlan R., Keen C. L., Gershwin M. E., Inflammation and oxidative stress in obstructive sleep apnea syndrome. Experimental Biology and Medicine 2007 232 11 1409 1413 2-s2.0-36849063168 10.3181/0704-MR-103
23. Yamauchi M., Tamaki S., Tomoda K., Yoshikawa M., Fukuoka A., Makinodan K., Koyama N., Suzuki T., Kimura H., Evidence for activation of nuclear factor kappaB in obstructive sleep apnea. Sleep and Breathing 2006 10 4 189 193 2-s2.0-33751082943 10.1007/s11325-006-0074-x
24. Carmeliet P., Dor Y., Herbert J. M., Fukumura D., Brusselmans K., Dewerchin M., Neeman M., Bono F., Abramovitch R., Maxwell P., Koch C. J., Ratcliffe P., Moons L., Jain R. K., Collen D., Keshert E., Role of HIF-1 α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature 1998 395 6701 485 490 2-s2.0-0032190083
25. Martinez D., Fiori C. Z., Baronio D., Carissimi A., Kaminski R. S., Kim L. J., Rosa D. P., Bos Â., Brown adipose tissue: is it affected by intermittent hypoxia? Lipids in Health and Disease 2010 9, article no. 121 2-s2.0-77957916540 10.1186/1476-511X-9-121
26. [Anon], AVMA updates its euthanasia guidelines. Veterinary Record 2007 161 15 502 502
27. [Anon], AVMA releases updated euthanasia guidelines. Journal of the American Veterinary Medical Association 2007 231 6 827 827
28. Bradford M. M., A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Analytical Biochemistry 1976 72 1-2 248 254 2-s2.0-0017184389
29. Buege J. A., Aust S. D., Microsomal lipid peroxidation. Methods in Enzymology 1978 52 302 310 2-s2.0-0017872475 10.1016/S0076-6879(78)52032-6
30. Misra H. P., Fridovich I., The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. Journal of Biological Chemistry 1972 247 10 3170 3175 2-s2.0-0015523099
31. Aebi H., Catalase in vitro. Methods in Enzymology 1984 105 121 126 2-s2.0-0021318441 10.1016/S0076-6879(84)05016-3
32. Laemmli U. K., Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970 227 5259 680 685 2-s2.0-0014949207 10.1038/227680a0
33. Towbin H., Staehelin T., Gordon J., Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proceedings of the National Academy of Sciences of the United States of America 1979 76 9 4350 4354 2-s2.0-0009482260
34. Shpirer I., Copel L., Broide E., Elizur A., Continuous positive airway pressure improves sleep apnea associated fatty liver. Lung 2010 188 4 301 307 2-s2.0-77955560224 10.1007/s00408-009-9219-6
35. Day C. P., James O. F. W., Steatohepatitis: a tale of two "Hits"? Gastroenterology 1998 114 4 842 845 2-s2.0-0031947715 10.1016/S0016-5085(98)70599-2
36. Seki S., Kitada T., Sakaguchi H., Clinicopathological significance of oxidative cellular damage in non-alcoholic fatty liver diseases. Hepatology Research 2005 33 2 132 134 2-s2.0-29144531843 10.1016/j.hepres.2005.09.020
37. George J., Pera N., Phung N., Leclercq I., Hou J. Y., Farrell G., Lipid peroxidation, stellate cell activation and hepatic fibrogenesis in a rat model of chronic steatohepatitis. Journal of Hepatology 2003 39 5 756 764 2-s2.0-0242438087 10.1016/S0168-8278(03)00376-3
38. Rosa D. P., Martinez D., Picada J. N., Semedo J. G., Marroni N. P., Hepatic oxidative stress in an animal model of sleep apnoea: effects of different duration of exposure. Comparative Hepatology 2011 10, article 1 2-s2.0-79959818879 10.1186/1476-5926-10-1
39. Park A. M., Suzuki Y. J., Effects of intermittent hypoxia on oxidative stress-induced myocardial damage in mice. Journal of Applied Physiology 2007 102 5 1806 1814 2-s2.0-34247866246 10.1152/japplphysiol.01291.2006
40. Dutta A., Ray K., Singh V. K., Vats P., Singh S. N., Singh S. B., L-carnitine supplementation attenuates intermittent hypoxia-induced oxidative stress and delays muscle fatigue in rats. Experimental Physiology 2008 93 10 1139 1146 2-s2.0-51749092435 10.1113/expphysiol.2008.042465
41. Bertuglia S., Reiter R. J., Melatonin reduces microvascular damage and insulin resistance in hamsters due to chronic intermittent hypoxia. Journal of Pineal Research 2009 46 3 307 313 2-s2.0-62449342906 10.1111/j.1600-079X.2008. 00662.x
42. Lavie L., Hefetz A., Luboshitzky R., Lavie P., Plasma levels of nitric oxide and L-arginine in sleep apnea patients: effects of nCPAP treatment. Journal of Molecular Neuroscience 2003 21 1 57 63 2-s2.0-0141450467 10.1385/JMN:21:1:57
43. Sohn H. Y., Krotz F., Gloe T., Keller M., Theisen K., Klauss V., Pohl U., Differential regulation of xanthine and NAD(P)H oxidase by hypoxia in human umbilical vein endothelial cells. Role of nitric oxide and adenosine. Cardiovascular Research 2003 58 3 638 646 2-s2.0-0037531465 10.1016/S0008- 6363(03)00262-1
44. Cairo G., Castrusini E., Minotti G., Bernelli-Zazzera A., Superoxide and hydrogen peroxide-dependent inhibition of iron regulatory protein activity: a protective stratagem against oxidative injury. The FASEB Journal 1996 10 11 1326 1335 2-s2.0-0029815291
45. Jordan W., Cohrs S., Degner D., Meier A., Rodenbeck A., Mayer G., Pilz J., Rüther E., Kornhuber J., Bleich S., Evaluation of oxidative stress measurements in obstructive sleep apnea syndrome. Journal of Neural Transmission 2006 113 2 239 254 2-s2.0-31044451221 10.1007/s00702-005-0316-2
46. Phillips S. A., Olson E. B., Lombard J. H., Morgan B. J., Chronic intermittent hypoxia alters NE reactivity and mechanics of skeletal muscle resistance arteries. Journal of Applied Physiology 2006 100 4 1117 1123 2-s2.0-33646356722 10.1152/japplphysiol.00994.2005
47. Mole D. R., Blancher C., Copley R. R., Pollard P. J., Gleadle J. M., Ragousis J., Ratcliffe P. J., Genome-wide association of hypoxia-inducible factor (HIF)-1 α and HIF-2 α DNA binding with expression profiling of hypoxia-inducible transcripts. Journal of Biological Chemistry 2009 284 25 16767 16775 2-s2.0-67650531089 10.1074/jbc.M901790200
48. Semenza G. L., Regulation of oxygen homeostasis by hypoxia-Inducible factor 1. Physiology 2009 24 2 97 106 2-s2.0-66149145306 10.1152/physiol.00045. 2009
49. Yuan G., Khan S. A., Luo W., Hypoxia-inducible factor 1 mediates increased expression of NADPH oxidase-2 in response to intermittent hypoxia. Journal of Cellular Physiology 2011 226 11 2925 2933
50. Nath B., Levin I., Csak T., Petrasek J., Mueller C., Kodys K., Catalano D., Mandrekar P., Szabo G., Hepatocyte-specific hypoxia-inducible factor-1 α is a determinant of lipid accumulation and liver injury in alcohol-induced steatosis in mice. Hepatology 2011 53 5 1526 1537 2-s2.0-79955096123 10.1002/hep.24256
51. Blouin C. C., Pagé E. L., Soucy G. M., Richard D. E., Hypoxic gene activation by lipopolysaccharide in macrophages: implication of hypoxia-inducible factor 1 α Blood 2004 103 3 1124 1130 2-s2.0-1642581653 10.1182/blood-2003-07-2427
52. Peyssonnaux C., Cejudo-Martin P., Doedens A., Zinkernagel A. S., Johnson R. S., Nizet V., Cutting edge: essential role of hypoxia inducible factor-1 α in development of lipopolysaccharide-induced sepsis. Journal of Immunology 2007 178 12 7516 7519 2-s2.0-34250158361
53. Moritz W., Meier F., Stroka D. M., Giuliani M., Kugelmeier P., Nett P. C., Lehmann R., Candinas D., Gassmann M., Weber M., Apoptosis in hypoxic human pancreatic islets correlates with HIF-1alpha expression. The FASEB Journal 2002 16 7 745 747 2-s2.0-0036584585
54. Akakura N., Kobayashi M., Horiuchi I., Suzuki A., Wang J., Chen J., Niizeki H., Kawamura K. I., Hosokawa M., Asaka M., Constitutive expression of hypoxia-inducible factor-l α renders pancreatic cancer cells resistant to apoptosis induced by hypoxia and nutrient deprivation. Cancer Research 2001 61 17 6548 6554 2-s2.0-0035418621
55. van Uden P., Kenneth N. S., Rocha S., Regulation of hypoxia-inducible factor-1 α a by NF- B. Biochemical Journal 2008 412 3 477 484 2-s2.0-45349097483 10.1042/BJ20080476
56. Rius J., Guma M., Schachtrup C., Akassoglou K., Zinkernagel A. S., Nizet V., Johnson R. S., Haddad G. G., Karin M., NF- B links innate immunity to the hypoxic response through transcriptional regulation of HIF-1 α Nature 2008 453 7196 807 811 2-s2.0-44849100198 10.1038/nature06905
57. Beraza N., Malato Y., Vander Borght S., Liedtke C., Wasmuth H. E., Dreano M., De Vos R., Roskams T., Trautwein C., Pharmacological IKK2 inhibition blocks liver steatosis and initiation of non-alcoholic steatohepatitis. Gut 2008 57 5 655 663 2-s2.0-42549144094 10.1136/gut.2007.134288
58. Pahl H. L., Activators and target genes of Rel/NF- B transcription factors. Oncogene 1999 18 49 6853 6866 2-s2.0-0033596121
59. Ferrara N., Vascular endothelial growth factor: basic science and clinical progress. Endocrine Reviews 2004 25 4 581 611 2-s2.0-4143136640 10.1210/er.2003-0027
60. Minet E., Michel G., Remacle J., Michiels C., Role of HIF-1 as a transcription factor involved in embryonic development, cancer progression and apoptosis. International Journal of Molecular Medicine 2000 5 3 253 259 2-s2.0-0034145215
61. Greijer A. E., Van Der Wall E., The role of hypoxia inducible factor 1 (HIF-1) in hypoxia induced apoptosis. Journal of Clinical Pathology 2004 57 10 1009 1014 2-s2.0-4944246547 10.1136/jcp.2003.015032